Esophageal Cancer clinical trials
Showing 51–100 of 128 active trials. Describe your situation to see which ones look like a fit.
- Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
- AMT-116 in Patients With Advanced Solid Tumors
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
- A Beta-only IL-2 ImmunoTherapY Study
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy
- A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
- PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
- Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
- Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
- The Vanguard Study: Testing a New Way to Screen for Cancer
- 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- Registry Study of People Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak
- Impact of RFA on Esophageal Distensibility and Mucosal Impedance
- Registry for Esophageal and Gastroesophageal Junction Cancer
- Volume Outcome Relationships and Effects
- Distribution of Lymph Node Metastases in Esophageal Carcinoma
- TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
- Mayo Clinic Upper Digestive Disease Survey
- Barrett's Esophagus Related Neoplasia (BERN) Project
- A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
- Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
- EsophaCap for the Detection of Early Esophageal Carcinoma
- Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
- Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
- DESTINY-PANTUMOUR04
- Pan-tumor MRD Study
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection
- Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
- Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
- Integrated Cancer Repository for Cancer Research
- Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
- Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
- Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
- Esophageal Cancer Risk Registry
- Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
- Exercise Prehabilitation for Locoregional Esophageal Cancer
- Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.